Biologics
Check out the latest Biologics news being talked about today across the world.
-
Kuros Biosciences Expands into Extremities Markets
Commercial Highlights Appointment of Jantzen…
Read More » -
NovaBone Receives FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications
November 12, 2024 – NovaBone…
Read More » -
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
– Blinded preliminary data demonstrate…
Read More » -
-
Orthobiologics Market Is Expected To Reach a Revenue Of USD 11.7 Bn By 2033, at 5.7% CAGR: Dimension Market Research
Advancements and Projections in the…
Read More » -
Theradaptive Announces Peer-Reviewed Publication in Spine of Preclinical Spinal Fusion Study of OsteoAdapt™ SP
OsteoAdapt SP demonstrated more robust…
Read More » -
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
– Allows for the processing…
Read More » -
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
Brings 30+ years of commercial…
Read More » -
Tetrous®Inc. Announces Issue of an Additional U.S. Patent Related to EnFix® Demineralized Bone Fiber Implants for Sports Medicine Surgical Procedures
LOS ANGELES, Oct. 15, 2024 /PRNewswire/ — Tetrous,…
Read More » -
Foot Innovate Welcomes New Corporate Partner: Kuros Biosciences
October 9, 2024 – OrthoSpineNews…
Read More » -
RTI Surgical Announces Agreement to Acquire Collagen Solutions
Further expands RTI’s soft tissue…
Read More » -
Enovis™ and Ossium Health® Forge a Strategic Partnership to Expand the Distribution of OssiGraft™ and OssiGraft Prime™
A Strategic Partnership Set to…
Read More » -
AlloSource Medical Director Dr. Hannis Thompson Recognized For His Exceptional Contributions In Tissue Banking At AATB Annual Meeting
CENTENNIAL, Colo., Oct. 3, 2024 /PRNewswire/ — AlloSource…
Read More » -
Altus Spine and Joint Pain Center Partners with Regenexx to Bring Revolutionary Non-Surgical Pain Management to the Rio Grande Valley
MCALLEN, Texas, Sept. 30, 2024 /PRNewswire-PRWeb/ — Altus…
Read More » -
Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use
Approval underscores Cerapedics’ commitment to…
Read More »